© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Invesco Nasdaq Biotechnology ETF (IBBQ) stock surged +0.09%, trading at $34.47 on NASDAQ, up from the previous close of $34.44. The stock opened at $34.84, fluctuating between $34.45 and $34.84 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 34.93 | 34.93 | 34.46 | 34.47 | 17.43K |
| Sep 10, 2026 | 34.91 | 34.91 | 34.41 | 34.41 | 19.84K |
| Sep 09, 2026 | 35.20 | 35.39 | 34.92 | 34.93 | 14.3K |
| Sep 08, 2026 | 35.59 | 35.62 | 35.07 | 35.20 | 23.76K |
| Sep 04, 2026 | 36.30 | 36.30 | 35.91 | 36.05 | 12.54K |
| Sep 03, 2026 | 36.39 | 36.52 | 35.91 | 36.26 | 35.22K |
| Sep 02, 2026 | 35.93 | 36.45 | 35.75 | 36.30 | 17.75K |
| Sep 01, 2026 | 35.51 | 35.80 | 35.48 | 35.79 | 39.94K |
| Aug 31, 2026 | 35.18 | 35.56 | 34.86 | 35.47 | 25.72K |
| Aug 28, 2026 | 36.38 | 36.38 | 35.39 | 35.47 | 27.67K |
| Aug 27, 2026 | 36.44 | 36.55 | 36.28 | 36.45 | 37.76K |
| Aug 26, 2026 | 36.78 | 36.78 | 36.42 | 36.57 | 21.57K |
| Aug 25, 2026 | 36.20 | 36.83 | 36.20 | 36.80 | 42.95K |
| Aug 24, 2026 | 36.34 | 36.34 | 35.73 | 36.11 | 49.29K |
| Aug 21, 2026 | 36.02 | 36.57 | 35.99 | 36.29 | 34.98K |
| Aug 20, 2026 | 36.30 | 36.30 | 35.69 | 35.80 | 29.75K |
| Aug 19, 2026 | 35.59 | 36.84 | 35.59 | 36.82 | 259.29K |
| Aug 18, 2026 | 34.33 | 34.65 | 34.33 | 34.62 | 6.2K |
| Aug 17, 2026 | 33.72 | 34.30 | 33.72 | 34.30 | 10.03K |
| Aug 14, 2026 | 33.91 | 33.91 | 33.38 | 33.81 | 9.4K |
Downers Grove, IL 60515
United States
https://www.invesco.com/us/en/financial-products/etfs/invesco-nasdaq-biotechnology-etf.html180 098 30903The Invesco Nasdaq Biotechnology ETF (IBBQ) seeks to mirror the investment performance of the Nasdaq Biotechnology Index. To achieve this, the Fund generally dedicates at least 90% of its total capital to the securities that make up this benchmark index. The underlying Index itself is specifically designed to gauge the returns of biotechnology and pharmaceutical companies whose shares are publicly traded on the Nasdaq Stock Market. Both the ETF and its corresponding Index undergo a yearly review and update of their composition each December, and their weightings are adjusted quarterly in March, June, September, and December.
| Employees | 0 |
| Beta | 0.61 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Financial Services |
| Industry | Asset Management - Global |